Structure of neprilysin in complex with the active metabolite of sacubitril

Sci Rep. 2016 Jun 15:6:27909. doi: 10.1038/srep27909.

Abstract

Sacubitril is an ethyl ester prodrug of LBQ657, the active neprilysin (NEP) inhibitor, and a component of LCZ696 (sacubitril/valsartan). We report herein the three-dimensional structure of LBQ657 in complex with human NEP at 2 Å resolution. The crystal structure unravels the binding mode of the compound occupying the S1, S1' and S2' sub-pockets of the active site, consistent with a competitive inhibition mode. An induced fit conformational change upon binding of the P1'-biphenyl moiety of the inhibitor suggests an explanation for its selectivity against structurally homologous zinc metallopeptidases.

MeSH terms

  • Aminobutyrates / chemistry*
  • Aminobutyrates / metabolism
  • Biphenyl Compounds / chemistry*
  • Biphenyl Compounds / metabolism
  • Catalytic Domain
  • Crystallography, X-Ray
  • Drug Combinations
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / metabolism
  • Humans
  • Hydrogen Bonding
  • Models, Molecular
  • Neprilysin / antagonists & inhibitors
  • Neprilysin / chemistry*
  • Neprilysin / metabolism*
  • Protein Domains
  • Tetrazoles / metabolism
  • Valsartan

Substances

  • Aminobutyrates
  • Biphenyl Compounds
  • Drug Combinations
  • Enzyme Inhibitors
  • LBQ657
  • Tetrazoles
  • Valsartan
  • Neprilysin
  • sacubitril and valsartan sodium hydrate drug combination